Abstract
ABSTRACT: The two principal dihydroxylated metabolites of the vitamin D prohormone 25-hydroxyvitamin D3 [25(OH)D3] are 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3, the active hormone] and 24R,25-dihydroxyvitamin D3 [24,25(OH)2D3, a putative regulator of developmental bone formation]. Although several studies have demonstrated placental synthesis of 1,25(OH)2D3 from 25(OH)D3, placental production of 24,25(OH)2D3 has not been thoroughly investigated. Therefore, we studied 25(OH)D3 metabolism in term human placenta using a villous explant model and cultures of isolated trophoblast and villous mesenchymal cells. We determined that both vitamin D-replete and vitamin D-deficient trophoblast metabolize 25(OH)D3 predominantly via 24-hydroxylation. Placental 24,25(OH)2D3 was identified by cochromatography with authentic standard on four different HPLC systems, scanning UV spectrophotometry profile of the metabolite, sensitivity to periodate cleavage, and mass spectrometry of the putative placental 24,25(OH)2D3 and its periodate cleavage product. We also identified for the first time placental synthesis of 23,25(OH)2D3 using cochromatography with authentic standard on two different HPLC systems, scanning UV spectrophotometry, resistance to periodate cleavage, and mass spectrometry. When trophoblast was incubated for up to 4 h with physiologic concentrations of [3H]25(OH)D3 (6 nM) significant amounts of [3H]24,25(OH)2D3 were produced, but ]3H]1,25(OH)2D3 could not be consistently detected. In contrast, when we incubated trophoblast with supraphysiologic concentrations of 25(OH)D3 (6–10 μM), both 24,25(OH)2D3 and 1,25(OH)2D3 were synthesized. These results provide unequivocal evidence for placental synthesis of both 24,25(OH)2D3 and 23,25(OH)2D3. These findings also suggest that supraphysiologic substrate concentrations saturate the placental 24-hydroxylase and may permit accumulation of placental 1,25(OH)2D3 by preventing its further metabolism. Consequently, the identification of this high basal 24-hydroxylase activity in trophoblast may explain inconsistencies among previous reports regarding placental 1,25(OH)2D3 production. We speculate that active placental 24-hydroxylation may serve important functions in perinatal vitamin D metabolism.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rubin, L., Yeung, B., Vouros, P. et al. Evidence for Human Placental Synthesis of 24,25-Dihydroxyvitamin D3 and 23,25-Dihydroxyvitamin D3. Pediatr Res 34, 98–104 (1993). https://doi.org/10.1203/00006450-199307000-00023
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199307000-00023